DRAP’s Safety Alert Regarding Mesalazine
DRAP’s Safety Alert Regarding Mesalazine! Risk of Idiopathic Intracranial Hypertension Associated with Mesalazine Date: 30 January 2026 Target Audience Provincial […]
Pharma Bulletin
DRAP issued Rapid Alert of Spurious Medicine
On 23rd january 2026, DRAP issued a Rapid Alert of Spurious Tablet EFASTON® DRAP Alert No: No I/S/01-26-136 Action Date:
DRAP’s Multiple Recalls Alerts About Adulterated, Substandard & Misbranded Medicines
DRAP’s Multiple Recalls Alerts About Adulterated, Substandard & Misbranded Medicines Recall Alert (Class-I) – BP-NORM Tablets (Substandard & Adulterated) DRAP
DRAP’s Multiple Recall Alerts of January-14, 2026
DRAP RAPID ALERT: UNREGISTERED & FALSIFIED COSMETIC AND TOPICAL PRODUCTS CONTAINING UNAUTHORIZED PHARMACEUTICAL INGREDIENTS DRAP Alert No: I/S/01-26-128Action Date: 14
DRAP Issues Multiple Alerts on Falsified, Unregistered, and Substandard Medicines
DRAP Recall ALERT: CRACKDOWN AGAINST UNLICENSED / UNAUTHORIZED MANUFACTURERS DRAP Alert No: I/S/12-25-124Action Date: 30 December 2025 Target Audience Regulatory
DRAP Recall Falsified, Spurious & Substandard Medicines
On December 18, 2025 – DRAP Recall Falsified/Spurious/ unregistered Tramadol tablets & Substandard betahist 16mg & Glitric 2.6mg Tablets DRAP
DRAP Recall Alert-Substandard batches of Ascard 75mg, PREVASMA Sachets and other medicines
DRAP Recall Alert-Substandard batches of Ascard 75mg, PREVASMA Sachets, Neudex injection and Ame-Pin injection Recall Alert No. 119 Class-II Recall
DRAP Recall-KANADEX-N cream’s Substandard Batches
Date: October 24, 2025DRAP Recall Alert No.: II/S/10-25-101 Target Audience: – National Regulatory Field Force– Healthcare Professionals (Physicians, Pharmacists, Nurses)–
DRAP Recalls substandard batches of Ascard, Amloshine, & Lignozin-A and Satamin injections
In the last week of September,2025 Drug regulatory authority of Pakistan has issued many recalls of substandard, misbranded and adulterated
DRAP Rapid Alert – Illegal & Unsafe Sildenafil Tablets (PENAGRA, VEGA, COBRA) Sold in Pakistan
Unregistered Indian-Origin Illegal & Unsafe Sildenafil Tablets (PENAGRA, VEGA, COBRA) Being Sold Illegally Recall Alert | September 12, 2025 DRAP
DRAP RECALL ALERT! MEDICINES OF UNLICENSED / UNAUTHORIZED MANUFACTURERS
DRAP Recall Alert No.: I/S/09-25-59 Date of Action: 10th September 2025 Intended Audience: Regulatory Field Force of DRAP and Provincial
DRAP ALERT- FALSIFIED / SPURIOUS DRUG PRODUCTS IDENTIFIED
DRAP Alert No: I/S/08-25-56Date of Action: 20th August 2025Intended Audience: Regulatory Field Force of DRAP and Provincial Drug Control Departments
DRAP recall More Batches of Famila 28F tablets along with other medicines
DRAP Alert No. II/S/08-25-55Action Date: 18 August 2025Target Audience: DRAP’s National Regulatory Field Force Provincial Drug Control Departments Hospitals, pharmacies,
DRAP Recall alert of Famila-28F Tablets
DRAP RECALLS-BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORATORY KARACHI. Target Audience: DRAP’s national regulatory field force
DRAP recall alert of “AMOXIL Suspension & AMOXIL forte Suspension”
DRAP RECALL ALERT OF “AMOXIL SUSPENSION AND AMOXIL FORTE SUSPENSION” due to complaint of Induction Seal. DRAP Alert No: II/V/08-25-53Date
FDA Seeks Public Opinion on Menopause Hormone Therapy Risks and Benefits
On July 17, 2025, the FDA brought together a panel of experts to discuss the benefits and risks of hormone
DRAP recall Substandard Medicines-27 June-2025
DRAP recall ⚠️Substandard Medicines⚕️-27 June-2025 The Directorate of Drug Control (DDC) Punjab has notify DRAP (drug regulatory authority of Pakistan)
DRAP Recall the Products Containing HYDROXYPROGESTERONE CAPROATE
DRAP RECALL ⚠️The PRODUCTS CONTAINING HYDROXYPROGESTERONE CAPROATE💉 DRAP (Drug regulatory authority of Pakistan has recalled and suspends the registration of
DRAP recall alert-23 June 2025
DRAP Recalls: Substandard Medicine : Famobex Suspension by Cibex (Pvt.) Ltd. The Drug Regulatory Authority of Pakistan (DRAP) has issued
Latest DRAP Recalls – June 2025 Drug Safety Update
DRAP Recall Alert⚠️Recall of Substandard “Tovir 0.5mg Tablet” having Batch No. 55, Manufactured by M/s Adamjee Pharmaceuticals (Pvt.) Ltd, Karachi.